Joanne Smith-Farrell is COO & Oncology at bluebird bio, Inc. (BLUE). They have made 13 open-market trades across 1 company since 2020, most recently 2021-01-06.
CIK 0001304048
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BLUE | 20,609 | $102K |
Shares reported on the most recent Form 4, priced at the 2021-01-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLUE | SELL | 2021-01-05 | 2021-01-08 | $45.05 | $60K | -5.6% | -3.5% | -41.8% |
| BLUE | SELL | 2020-12-02 | 2020-12-04 | $46.20 | $2K | -5.4% | -5.0% | -40.6% |
| BLUE | SELL | 2020-11-02 | 2020-11-04 | $52.97 | $2K | -4.0% | -3.0% | -4.0% |
| BLUE | SELL | 2020-10-02 | 2020-10-06 | $52.77 | $2K | -0.4% | -13.3% | -20.7% |
| BLUE | SELL | 2020-09-03 | 2020-09-08 | $58.60 | $2K | -0.1% | +1.8% | -20.0% |
| BLUE | SELL | 2020-08-25 | 2020-08-27 | $58.95 | $13K | +1.8% | -0.8% | -23.3% |
| BLUE | SELL | 2020-08-03 | 2020-08-05 | $60.48 | $2K | -1.5% | -10.9% | -13.7% |
| BLUE | SELL | 2020-07-02 | 2020-07-07 | $61.57 | $2K | +2.8% | -0.9% | -12.9% |
| BLUE | SELL | 2020-06-04 | 2020-06-08 | $65.23 | $11K | -6.4% | -3.1% | -17.7% |
| BLUE | SELL | 2020-06-02 | 2020-06-04 | $64.03 | $2K | -7.0% | -14.4% | -12.5% |
| BLUE | SELL | 2020-05-04 | 2020-05-05 | $50.17 | $12K | +1.2% | +19.5% | +12.1% |
| BLUE | SELL | 2020-04-06 | 2020-04-08 | $43.73 | $25K | +25.4% | +35.6% | +47.0% |
| BLUE | SELL | 2020-01-07 | 2020-01-09 | $89.97 | $37K | +2.9% | -0.6% | -52.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.